Celldex Therapeutics (CLDX) stock forecast for 2022 – 2027

Are you interested in Celldex Therapeutics, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the CLDX stock price in 2022-2027. Is CLDX a good long term stock? When should I take profit in Celldex Therapeutics stock? Buy or sell stock? Will CLDX stock price go up? What are analysts’ forecasts for CLDX stock?
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. CLDX stock returns are also predicted based on historical data.

According to our research, CLDX stock is a outstanding long-term investment. CLDX share price has been in a positive cycle for the past year. Celldex Therapeutics, Inc. stock trend is positive.

Celldex Therapeutics company info

Industry Biotechnology
Address Perryville III Building, Hampton, NJ, 08827, United States
Website https://www.celldex.com

Forecasting

52 Week High: 45.8969 USD
52 Week Low: 30.3717 USD
1 Year Forecast: 44.547 USD
5 Year Forecast: 104.094 USD

Agilent Technologies info

Market Cap: 1.45B
52 Week Change: 9.232%
52 Week High: 57.2 USD
52 Week Low: 15.37 USD
Beta: 1.55143
50 Day Moving Average: 35.23
90 Day Moving Average: 37.953
200 Day Moving Average: 44.09
Resistance Level: 32.0754
Pivot Point: 30.58
Support Level: 29.4372
Enterprise Value: 1,414,813,440
Forward P/E: -16.58
Forward EPS: -1.75
Profit Margin: 0.00%
Shares Outstanding: 46,663,900
EBITDA: -25.36
Held Percent Institutions: 94.60%
PEG Ratio (5Y): 0
Trailing EPS: -1.76

Celldex Therapeutics stock forecasts for 2022-2027

DateOpen PriceClose PriceChange

Celldex Therapeutics Stock Forecast for 2022

March 2022 31.68 32 1.01%
April 2022 31.36 33.66 7.33%
May 2022 33.33 34 2.01%
June 2022 35.7 36.36 1.85%
July 2022 36 37.24 3.44%
August 2022 38.38 39.78 3.65%
September 2022 39.39 41.82 6.17%
October 2022 41.41 41 -0.99%
November 2022 41.82 41.58 -0.57%
December 2022 42.42 43.86 3.39%

Celldex Therapeutics Stock Forecast for 2023

January 2023 43.86 43.56 -0.68%
February 2023 43.56 46.06 5.74%
March 2023 47 46.06 -2%
April 2023 46.06 48.96 6.3%
May 2023 47.04 49 4.17%
June 2023 50.5 51.51 2%
July 2023 52.52 51.94 -1.1%
August 2023 53 55.08 3.92%
September 2023 53.46 57.12 6.85%
October 2023 54.88 55.44 1.02%
November 2023 57.12 57.57 0.79%
December 2023 55.86 56.84 1.75%

Celldex Therapeutics Stock Forecast for 2024

January 2024 58 59 1.72%
February 2024 58.41 61.38 5.08%
March 2024 62.62 63.24 0.99%
April 2024 62 63.63 2.63%
May 2024 63.63 66.3 4.2%
June 2024 63.7 66.66 4.65%
July 2024 67.67 68.68 1.49%
August 2024 66.64 70.38 5.61%
September 2024 67.62 71 5%
October 2024 72.42 69.58 -3.92%
November 2024 71 72 1.41%
December 2024 70.56 73 3.46%

Celldex Therapeutics Stock Forecast for 2025

January 2025 73.73 72.52 -1.64%
February 2025 75 75.46 0.61%
March 2025 75.46 77 2.04%
April 2025 75.46 76.44 1.3%
May 2025 79.56 81.6 2.56%
June 2025 80 82 2.5%
July 2025 81.18 83.83 3.26%
August 2025 84.84 82.32 -2.97%
September 2025 83.16 84.28 1.35%
October 2025 84.28 84.28 0%
November 2025 85.14 85.26 0.14%
December 2025 88.74 88.88 0.16%

Celldex Therapeutics Stock Forecast for 2026

January 2026 88.88 87.22 -1.87%
February 2026 88.2 92 4.31%
March 2026 93.84 90.16 -3.92%
April 2026 92.92 91.14 -1.92%
May 2026 92.07 94.05 2.15%
June 2026 95 96.03 1.08%
July 2026 97.97 97.02 -0.97%
August 2026 99 99 0%
September 2026 97.02 98.98 2.02%
October 2026 103.02 102.01 -0.98%
November 2026 102.01 100.98 -1.01%
December 2026 102 105.06 3%

Celldex Therapeutics Stock Forecast for 2027

January 2027 101.97 106.08 4.03%